News Center

Discover all of the trending news of the Ipsen Group


12 results

Financial information

Ipsen – Full Year 2019 Results Conference Call – February 13, 2020 at 2:30pm CET / 8:30 EST

Date:            Thursday, February 13, 2020 Time:            Conference call and webcast – 2:30pm CET / 8:30 EST…

Neuroscience

Ipsen in Neuroscience: A new decade of technological possibilities for Neuroscience at Ipsen

John Chaddock, VP Interim Global Head Neuroscience Therapeutic Area, Site Head Ipsen Bioinnovation, Ipsen As…

Neuroscience

From collaboration to evaluation: developing a new way to evaluate patient wellbeing in NETs

Working with patients, for patients, underlines everything we do at Ipsen. Understanding their quality of…

Group

2020 priorities: our path forward is clear

Developing new and innovative treatments for patients is our mission here at Ipsen, and we…

Group

Demerger of Mayroy SA and Internal reclassification of Ipsen shares

Luxembourg (France), 19 December 2019 – As previously announced in a press release dated November…

CSR

On World Anti-Corruption Day, Ipsen re-affirms its commitment to the principles of the United Nations Global Compact Program

Understanding the importance of conducting business with the highest ethical standards, we asked Dominique…

CSR

Always the innovator, Ipsen introduces social responsibility to its external funding conditions

Ipsen has further bolstered its CSR commitment by adding social responsibility criteria to its new…

Oncology

Ipsen in Oncology: Mo’tivated for Movember and beyond

Bartek Bednarz, SVP Global Product and Portfolio Strategy, Ipsen November has become synonymous with Movember,…

Oncology

Ipsen in Oncology: Unlocking the power of data

[caption id="attachment_6816" align="alignleft" width="150"] Bartek Bednarz, SVP Global Product and Portfolio Strategy, Ipsen[/caption] We’re excited…

Neuroscience

World Stroke Day: When it comes to stroke, Don’t Be the One.

World Stroke Day is on Tuesday, 29 October, and the World Stroke Organization will…

Financial information

Ipsen – 2019 Q3 results – October 24, 2019 at 2:30pm CEST

To register to the webcast, please click here. Ipsen will hold a conference call Thursday,…

Patient

Ipsen’s first clinical trial lay summary developed with patients, for patients

Here at Ipsen, we are committed to working with patients, for patients. As part of…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2020